BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
calcium channel activity
,
Breast Cancer
,
Adipose tissue
,
Laryngoscope
,
Doxorubicin
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
interleukin-6 binding
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
Lymph nodes
Liver
Synovial membrane
Saphenous vein
Lung
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Vesicular stomatitis Indiana virus disease
Meningitis
Listeriosis
Viral infections of the central nervous system
Multiple organ failure
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Ifna protein, mouse
niguldipine
Serum Albumin
eperisone
MLN8054
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
RAD54L
UBA52
RNR1
LCP2
RIOK2
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
L1000 CMAP Breast cancer MCF7 cells with gene overexpression perturbations
L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
L1000 CMAP Prostate cancer PC3 cells with gene overexpression perturbations (1 of 2)
L1000 CMAP Prostate cancer PC3 cells with gene overexpression perturbations (2 of 2)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
Explore Curated Studies Results
Literature
Most Relevant Literature
The Soluble Interleukin 6 Receptor: Advanced Therapeutic Options in Inflammation.
The soluble interleukin-6 receptor and related proteins.
c/EBPbeta is a major regulatory element driving transcriptional activation of the CXCL12 promoter.
Inhibitory effects of ginsenoside-Rb1 on activation of the 12-O-tetradecanoylphorbol 13-acetate-indu…
Emerging biologic therapies in rheumatoid arthritis: cell targets and cytokines.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Study of the Role of Soluble Inhibitor of Interleukin 22, Interleukin 22 Binding Protein (IL-22BP), …
Treatment With Dinutuximab Beta, Zoledronic Acid and Low-dose Interleukin (IL-2) in Patients With Le…
Effect of Interleukin 6 Receptor Antagonists in Corona Virus Disease 19 Patients Known by WHO
Monoclonal Antibody Therapy With Sargramostim and Interleukin-2 in Treating Children With Neuroblast…
Serum Interleukin - 17A in Juvenile Idiopathic Arthritis
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ